Category: 3. Business

  • Treasuries Fall as Jobs Data Curb Bets on Fed Cuts: Markets Wrap

    Treasuries Fall as Jobs Data Curb Bets on Fed Cuts: Markets Wrap

    (Bloomberg) — A much stronger-than-anticipated US jobs report spurred a slide in Treasuries as traders trimmed bets on Federal Reserve rate cuts this year. An initial rally in stocks waned amid a selloff in software companies.

    Short-dated Treasuries were hit the hardest, with two-year yields set for their biggest increase since October. Money markets priced in the Fed’s next cut in July, from June previously. The S&P 500, which had earlier risen on hopes that economic strength would keep fueling earnings, was little changed. Most megacaps fell and an ETF tracking software giants tumbled 3%. Bitcoin sank to around $66,500.

    US payrolls rose in January by the most in more than a year and the unemployment rate unexpectedly fell, suggesting the labor market continued to stabilize.

    Employers added 130,000 jobs last month and the unemployment rate slid to 4.3%. That followed revisions to the prior year, which showed a marked slowdown in hiring. Job gains averaged just 15,000 a month last year, down from the initially reported 49,000 pace.

    “Markets may have been expecting a downshift in today’s numbers after last week’s soft data, but the jobs market hit the gas pedal instead,” said Ellen Zentner at Morgan Stanley Wealth Management. “Today’s data shows an acceleration in employment that was strong enough to drive unemployment lower.”

    This is the kind of report investors should welcome — even if it gives the Fed more room to stay put, said Bret Kenwell at eToro.

    “Still, it’s important to keep perspective: this is one data point, and it doesn’t erase the recent softness elsewhere in the data. But if the labor market is indeed stabilizing, that would be constructive for both the economy and the market,” he said.

    The bigger implication may be for stocks given that a stronger job market will likely support the “broadening trade,” according to Brad Conger at Hirtle Callaghan.

    Ahead of the release of the report, traders were betting on a softer jobs data following the release of several downbeat job market indicators, noted Fawad Razaqzada at Forex.com. As it turned out, it was quite the opposite, he said

    “The better-than-expected job numbers for January are a bright spot in an otherwise uncertain labor market,” said Jerry Tempelman at Mutual of America Capital Management.

    If the recent jitters in the stock market are due to concerns of a weakening labor market and/or economy that is headed toward a recession, this report should alleviate those concerns in the short run, according to Chris Zaccarelli at Northlight Asset Management.

    “Until we see significant weakness in the labor market, the economy or corporate profits, we believe this is still a market where dips can be bought,” he said.

    The jobs report checked all the boxes today with better headline results, stronger participate rates, and the unemployment rate ticking lower, noted Art Hogan at B. Riley Wealth.

    Despite labor market softening observed last year, economic strength is likely coming out of 2025 and carrying into this year — and that should leave companies reluctant to fire, while tight labor supply should keep a lid on the unemployment rate, noted Jennifer Timmerman at Wells Fargo Investment Institute.

    Investors are shifting from trading headlines to focusing on earnings durability, balance-sheet strength, and selective growth, knowing volatility and rotation are likely as 2026 unfolds, according to Gina Bolvin at Bolvin Wealth Management Group.

    “The market got the jobs report it needed,” said Brad Smith at Janus Henderson Investors. “Despite tight spreads and elevated multiples, we view this as a favorable backdrop for risk assets.”

    Worst-case scenarios didn’t play out thanks to a private-sector rebound, according to David Russell at TradeStation. Today’s numbers seem to confirm the manufacturing rebound we’ve recently seen

    “It’s good news for people worried about an imminent slowdown, but it also reduces the urgency to cut interest rates,” he said.

    Looking through the noise, today’s print is a positive for risk assets given it shows a solid labor backdrop that can fuel further upside in consumption, said Jeff Schulze at ClearBridge Investment.

    The release provides ammunition to the Fed hawks to maintain a patient approach to rate cuts, reinforcing the narrative of a stabilizing labor market, according to Angelo Kourkafas at Edward Jones

    “Markets have adjusted accordingly, with bond futures now fully pricing in a Fed cut by July instead of June. From a portfolio standpoint, we expect the 10‑year yield to drift back toward the middle of its 4%–4.5% range, and we believe the rotation toward ‘old economy’ and pro‑cyclical sectors should continue,” he said.

    The relatively healthy state of the labor market suggests that rate cuts are not imminently needed, which allows the Fed some time to digest incoming data before determining the appropriate course of action moving forward, noted Jason Pride at Glenmede.

    “Investors should expect a base case of ~2 rate cuts in 2026, which are more likely to come under the leadership of the next Fed chair,” he said.

    “Today’s employment report was a 10 out of 10 with positive surprises across the board,” said Peter Graf at Amova Asset Management Americas. “It should quell recent concerns about growth, but puts incoming Fed Chair Warsh in the hot seat — it will be even harder to persuade the FOMC members to go along with the President’s mandate to cut rates.

    Interest-rate swaps after the data showed traders see less than 5% of a chance that policymakers lower rates when they meet in March. Traders have priced in a total of 49 basis points of policy easing by December — implying about two quarter-point rate cuts this year, compared with 59 basis points on Tuesday.

    An improving employment outlook should allow the Fed to shift its attention toward the inflation mandate and its anticipated progress for 2026, according to Oscar Munoz and Gennadiy Goldberg at TD Securities.

    They continue to forecast quarterly rate cuts of 25 basis points but now in June, September, and December, bringing the Fed funds rate to our projected terminal of 3%.

    “Expected easing won’t be the result of worsening economic conditions, but rather the normalization of policy as inflation gradually returns to its target,” they said.

    The labor market is showing some tentative signs of re-tightening, although there remains a way to go, according to Kay Haigh, at Goldman Sachs Asset Management.

    “The FOMC’s gaze instead will turn to the inflation picture with the economy continuing to perform above expectations,” he said. “We still see room for two more cuts this year; however, an upside surprise in the CPI on Friday could tilt the balance of risks in a hawkish direction.”

    Corporate Highlights:

    T-Mobile US Inc. reported it added fewer mobile-phone subscribers than analysts expected in the fourth quarter, highlighting the challenge ahead for new Chief Executive Officer Srini Gopalan. Kraft Heinz Co. halted plans to split in two, a surprising reversal weeks after bringing in a new chief executive officer with experience breaking up a food company. Shopify Inc. beat analysts’ fourth-quarter estimates after strong holiday spending lifted revenues at the e-commerce firm. Humana Inc. forecast profit that fell short of Wall Street’s expectations for the year, the latest insurer to disappoint investors as the industry grapples with rising costs and government pressure. Ford Motor Co. expects profit to jump in 2026 even after a surprise $900 million tariff bill at the end of last year dented the carmaker’s earnings. Lyft Inc. issued a disappointing forecast that missed Wall Street expectations, a sign that its global expansion and new product offerings are not performing as quickly and as well as anticipated. Nike Inc. expects its wholesale business to pick up steam across the world as it accelerates the launch of new footwear and apparel products and doubles down on its commitment to sports. Chevron Corp., Eni SpA, QatarEnergy and Repsol SA were among major energy companies that won rights to explore for oil and gas in Libya, the latest sign that the nation that holds Africa’s largest crude reserves is opening up for investments following years of civil war. Robinhood Markets Inc. reported lower fourth-quarter profit as sharp declines in Bitcoin and other cryptocurrencies weighed on results at the online brokerage. Gilead Sciences Inc. forecast 2026 product revenue and profit that missed analysts’ expectations, even after it outperformed during last year’s fourth quarter. US regulators refused to review Moderna Inc.’s novel mRNA flu vaccine, dealing a major blow to the company as it seeks more products beyond its Covid shot. Domino’s Pizza Enterprises Ltd. named McDonald’s Corp. veteran Andrew Gregory as its new global chief executive officer, charging him with turning around the chain’s flagging fortunes. Toymaker Mattel Inc. reported holiday results that fell short of analysts’ estimates and issued a 2026 forecast for lower profit. Activist investor Ancora Holdings Group is urging the board of Warner Bros. Discovery Inc. to reject the offer by Netflix Inc. and reconsider a competing bid by Paramount Skydance Corp., adding a new plot twist to one of Hollywood’s biggest takeover battles. Cloudflare Inc. reported quarterly results that showed continued demand for its security and performance services, as enterprises prioritized network resilience and application protection. Hilton Worldwide Holdings Inc. reported fourth quarter earnings that beat expectations, as the company’s ability to add new hotels to its global network drove growth. The Federal Communications Commission said it hasn’t received a letter from 40 Congressional Republicans opposing the proposed merger of broadcasters Nexstar Media Group Inc. and Tegna Inc. Elliott Investment Management has built a stake in London Stock Exchange Group Plc as the FTSE 100 index owner grapples with disruption from artificial intelligence and a plunge in listings, a person with knowledge of the investment said. Commerzbank AG’s improved outlook for this year failed to sway investors, underscoring the challenges for Chief Executive Officer Bettina Orlopp as she continues to defend the bank against a potential takeover. ABN Amro Bank NV reported fourth-quarter profit that missed analyst expectations on higher-than-expected expenses and provisions for bad loans. Heineken NV will cut about 7% of its workforce to contend with an industry-wide slump in beer demand triggered by rising prices and consumers moderating their alcohol consumption. Bombardier Inc. won a 40-plane order for its Challenger 3500 aircraft from Vista Global Holding Ltd., one of the world’s biggest operators of business jets, amid growing global demand for private aviation. Dassault Systemes SE gave weak guidance, stoking concerns that artificial intelligence will disrupt its business model and turning the stock into one of the biggest targets yet of a fear-driven selloff in businesses viewed as vulnerable to AI. TotalEnergies SE trimmed its share buybacks to the lower end of its guidance range, aiming to keep debt in check as it adjusts to lower oil prices. Samsung Electronics Co. will unveil its latest mainstream Galaxy smartphones on Feb. 25 at an event in San Francisco, hoping to spur upgrades and fresh momentum in its rivalry with Apple Inc.’s iPhone and Android-based competitors. ASX Ltd. said chief executive Helen Lofthouse will leave the role in May, without naming a successor as the Australian exchange grapples with challenges including a regulatory probe. Some of the main moves in markets:

    Stocks

    The S&P 500 was little changed as of 10:57 a.m. New York time The Nasdaq 100 rose 0.2% The Dow Jones Industrial Average fell 0.4% The Stoxx Europe 600 was little changed The MSCI World Index was little changed Bloomberg Magnificent 7 Total Return Index was little changed Philadelphia Stock Exchange Semiconductor Index rose 1.7% IShares Expanded Tech-Software Sector ETF fell 3% The Russell 2000 Index fell 1.1% Currencies

    The Bloomberg Dollar Spot Index was little changed The euro fell 0.3% to $1.1862 The British pound was little changed at $1.3638 The Japanese yen rose 0.5% to 153.55 per dollar Cryptocurrencies

    Bitcoin fell 3% to $66,582.23 Ether fell 3.8% to $1,932.33 Bonds

    The yield on 10-year Treasuries advanced three basis points to 4.17% Germany’s 10-year yield was little changed at 2.80% Britain’s 10-year yield declined two basis points to 4.48% The yield on 2-year Treasuries advanced six basis points to 3.51% The yield on 30-year Treasuries advanced two basis points to 4.81% Commodities

    West Texas Intermediate crude rose 1.5% to $64.94 a barrel Spot gold rose 0.7% to $5,059.78 an ounce ©2026 Bloomberg L.P.

    Continue Reading

  • IATA Wings of Change Americas Conference to Be Hosted in Santiago de Chile

    IATA Wings of Change Americas Conference to Be Hosted in Santiago de Chile

    Translation: La Conferencia Wings of Change Americas de IATA se Celebrará en Santiago de Chile (pdf)

     

    Miami – The International Air Transport Association (IATA) announced that this year’s Wings of Change Americas (WOCA) Conference will be taking place on 8-9 April in Santiago de Chile, with LATAM as the host airline.

    The 16th edition of the aviation industry’s premier event in Latin America and the Caribbean is being held under the theme “Beyond Borders – Aviation as a Catalyst for Economic Transformation” and will focus on how strategic collaboration between the aviation sector and government authorities can:

    • Expand regional connectivity
    • Accelerate economic growth, and
    • Strengthen global competitiveness

    The various panel discussions will highlight the critical importance of collaboration between the aviation industry and governmental bodies, as the key enabler for economic development and transformation. Moreover, industry relevant topics such as the role of technology and AI, sustainability, and the significance of air cargo will also be featured.

    More than 400 industry leaders and stakeholders are expected to attend the event.

    Peter Cerdá, Regional Vice President for the Americas, IATA, will be speaking at the event together with many of the region’s top airline CEOs including:

    • Roberto Alvo – CEO, LATAM Airlines Group
    • Daniel Belaunde – CEO, Sky Airline
    • Adrian Neuhauser – CEO, Abra Group
    • Gabriel Oliva – President of Avianca Group
    • Estuardo Ortiz – CEO, JetSMART Airlines

    Reflecting the conference’s objective to create solutions across the aviation value chain, the various panel discussions will include:

    • Sustainability & Innovation – Overcoming Barriers toward Net Zero Carbon Emissions in Latin America
    • Airport Executive Roundtable – Powering the Next Generation of Infrastructure in the Americas
    • Regulatory Roundtable – Balancing Consumer Protection & Industry Viability
    • Air Cargo & Logistics – Unlocking Trade Potential in the Americas
    • Code, Cloud, Cabin – AI’s Triple Play in Aviation

    WOCA will also be the first aviation industry event in Chile to welcome representatives of the country’s newly elected administration.

    Aviation is a key contributor to economic and social development across Latin America and the Caribbean. The sector supports more than 8.3 million jobs and generates an economic contribution of some USD 240 billion in GDP (2023). Estimates show that these figures are set to nearly double by 2043 to 15 million supported jobs and USD 500 billion in GDP contribution.

    > View the full details and current program

    Media wishing to be accredited for the event should do so via the registration page.


     

    For more information, please contact:

    Corporate Communications
    Tel: +1 438 258 3155
    Mobile: +1 514 240 4746
    Email: ruedigerm@iata.org

    Notes for Editors:

    • IATA (International Air Transport Association) represents over 360 airlines accounting for some 85% of global air traffic.
    • You can follow us on X for announcements, policy positions, and other useful industry information.
    • Fly Net Zero

    Continue Reading

  • New biosensor technology could improve glucose monitoring | WSU Insider

    New biosensor technology could improve glucose monitoring | WSU Insider

    PULLMAN, Wash. – A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for people with diabetes, making it more cost-effective, accurate, and less invasive than current models.

    The WSU researchers have developed a wearable and user-friendly sensor that uses microneedles and sensors to measure sugar in the fluid around cells, providing an alternative to continuous glucose monitoring systems. Reporting in the journal Analyst, the researchers were able to accurately detect sugar levels and wirelessly transmit the information to a smartphone in real-time.

    “We were able to amplify the signal through our new single-atom catalyst and make sensors that are smaller, smarter, and more sensitive,” said Annie Du, research professor in WSU’s College of Pharmacy and Pharmaceutical Sciences and co-corresponding author on the work. “This is the future and provides a foundation for being able to detect other disease biomarkers in the body.”

    Measuring glucose levels is important for diabetes, helping to keep patients healthy and preventing complications. Continuous glucose monitors on the market require the use of small needles to insert the monitor, and people can get skin irritation or rashes from the chemical processes that are done under the skin. Furthermore, they’re not always sensitive enough.

    The researchers used 3D printing to create their sensor, which makes it relatively inexpensive compared to typical monitors. The sensor uses a button-activated pump and tiny hollow microneedles to extract fluid from around the cells and tissue below the skin for testing. Unlike other glucose monitors that can cause inflammation and pain at the testing site, the testing process occurs outside the body, lowering potential toxicity for patients.

    “Ours is much more benign for customers and users,” said Kaiyan Qiu, Berry Assistant Professor in WSU’s School of Mechanical and Materials Engineering and corresponding author on the work.

    The hollow microneedle arrays are less than a millimeter in length as compared to typical glucose monitoring needles that are several times longer.  

    “The hollow microneedles are painless and minimally invasive, making them next-generation medical devices,” said Qiu.

    The glucose monitor is also highly sensitive because it uses a single-atom catalyst and enzymatic reactions, called nanozymes, to enhance the sugar’s signal and measure low levels of the biomarkers.

    “The nanozymes make our signal much stronger and can detect a minimal amount of any biomarker,” said Qiu.

    The researchers have filed a provisional patent in the Office of Innovation and Entrepreneurship. They are planning to test the glucose monitors on animals and are investigating its use with additional or multiple biomarkers. The revenue from continuous glucose monitor market in the United States is forecasted to nearly quadruple, from $7.2 billion in 2024 to $26.8 billion in 2033. 

    “My goal is to make advanced sensing technology more practical for everyday healthcare,” said Yonghao Fu, co-first author on the paper and a PhD student in the School of Mechanical and Materials Engineering. “I enjoy working on a project that can combine different technologies so that we can take advantage of their strengths.”

    The work was funded by the National Science Foundation and the Centers for Disease Control and Prevention.

    Continue Reading

  • BorgWarner Secures Its First 48V Electric Cross Differential Program

    • BorgWarner expands its 48V electric vehicle technology portfolio in China 
    • First 48V electric cross differential (eXD) program award in BorgWarner’s global portfolio

    Auburn Hills, Michigan, February 11, 2026 – BorgWarner has secured a new electric cross differential (eXD) program with a leading Chinese original equipment manufacturer (OEM). The eXD solution is designed for a 48V system and is integrated with the customer’s 48V electrical and electronic (E/E) architecture. This program represents BorgWarner’s first 48V eXD application within its global portfolio and expands the company’s torque management capabilities for electric vehicles.

    As the electric vehicle market continues to evolve, E/E architectures are transitioning toward higher efficiency and greater integration. A 48V electrical architecture offers advantages including improved energy efficiency, optimized wiring and component costs, and support for higher-power applications. Leveraging this architecture, BorgWarner’s eXD is built to dynamically control torque distribution between wheels, enhancing vehicle handling and traction while maintaining a balance between performance, safety, and system efficiency.

    “We believe BorgWarner’s eXD technology enhances handling and vehicle stability across a wide range of driving conditions,” said Isabelle McKenzie, Vice President of BorgWarner Inc. and President and General Manager, Drivetrain and Morse Systems. “Securing our first 48V eXD program demonstrates our ability to adapt proven torque management technologies to new electrical architectures. By leveraging a 48V system, the eXD is expected to improve energy utilization, system efficiency, and reliability, which will elevate the driving experience for electric vehicle users.

    BorgWarner’s eXD is engineered to dynamically adjust slip control based on real-time driving conditions and vehicle status, supporting vehicle stability during high-speed driving, rapid acceleration, and sharp turns. The eXD is also intended to deliver consistent handling performance across varying friction conditions. On dry roads, higher friction enables improved grip, and we expect this will allow the eXD to transfer more torque to the outer wheels for enhanced cornering performance. In low-friction environments such as ice, snow, or mud, the system is designed to rapidly detect wheel slip and limit torque transfer to slipping wheels, which will reallocate drive force to wheels with better traction to maintain stability and control.

    Continue Reading

  • Oatly banned from using word ‘milk’ to market plant-based products in UK | Food & drink industry

    Oatly banned from using word ‘milk’ to market plant-based products in UK | Food & drink industry

    The Swedish-based drinks manufacturer Oatly has been banned from using the word “milk” to market its plant-based products, after a ruling by the UK supreme court.

    The alt-milk manufacturer has been in a long-running legal battle with the trade association Dairy UK after Oatly trademarked phrases associated with the dairy sector.

    On Wednesday the supreme court unanimously ruled that Oatly can no longer trademark, or use, the slogan “Post Milk Generation”.

    “It has taken the highest court in the land to decide once and for all whether a plant-based milk alternative can be branded as ‘milk’ and marketed as such,” said Laurie Bray, a senior associate and trademark attorney at the European intellectual property company Withers & Rogers. “And the outcome is not what Oatly was hoping for.”

    Regulations state that certain terms can only be used to denote the actual products they describe, such as milk, wine and olive oil. Milk is defined as coming from the dairy sector and, more specifically, animals.

    However, Oatly, which first filed a trademark application for the term “Post Milk Generation” with the UK’s Intellectual Property Office in 2019 – which was registered officially in 2021 – had argued that the use of the term ”milk” in a trademark did not breach regulations if it was not being used in a descriptive manner.

    In 2023, after an objection from Dairy UK, the IPO ruled that the use of the word “milk” in this way was “deceptive”; Oatly successfully appealed against the ruling in December 2023, but that decision was then overturned by the court of appeal, prompting it to take the issue to the supreme court.

    The supreme court ruling has wider ramifications for producers of plant-based alternatives, and Oatly’s trademark registrations in other European countries could now be challenged by equivalent trade bodies to Dairy UK.

    The same regulations apply to terms that are derived from other milk-based products such as cream, butter, cheese and yoghurt.

    “For plant-based producers the safer course is to use clearly descriptive alternatives such as ‘oat drink’, or ‘plant-based drink’,” said Richard May, a partner at Osborne Clarke. “More broadly, the judgment signals that UK regulators and courts are likely to take a robust approach to so-called ‘category borrowing’ across regulated sectors. Businesses building brands around legally defined product names, whether in dairy or elsewhere, should expect careful scrutiny and plan their brand strategy accordingly.”

    In 2021, Glebe Farm Foods, a Cambridgeshire-based company that specialises in producing gluten-free oats, won a trademark infringement battle brought by Oatly over its use of the brand name PureOaty.

    Continue Reading

  • Vertiv Reports Strong Fourth Quarter with Organic Orders Growth of 252% and Diluted EPS Growth of 200% (Adjusted Diluted EPS +37%)

    Vertiv Reports Strong Fourth Quarter with Organic Orders Growth of 252% and Diluted EPS Growth of 200% (Adjusted Diluted EPS +37%)

    Fourth Quarter 2025

    • Net sales of $2,880 million, 23% higher than fourth quarter 2024
    • Operating profit up 27% and adjusted operating profit(1) up 33% from fourth quarter 2024. Adjusted operating margin of 23.2%, up 170 basis points compared to fourth quarter 2024
    • Operating cash flow of $1,005 million and adjusted free cash flow(1) of $910 million, an increase of 136% and 151%, respectively, compared to prior year fourth quarter. Net leverage of ~0.5x at the end of fourth quarter

    Full Year 2025

    • Organic sales growth of 26% compared to prior year. Full year diluted EPS growth of 166% and adjusted diluted EPS growth of 47%. Full year operating cash flow of $2,114 million and adjusted free cash flow of $1,887 million, an increase of 60% and 66%, respectively, compared to prior year

    Full Year 2026

    • Expect net sales of $13,250 to $13,750 million, with organic sales growth of 27% to 29% compared to 2025
    • Expect full year 2026 diluted EPS of $5.27 to $5.37 and adjusted diluted EPS of $5.97 to $6.07, an increase of 56% and 43%, respectively, at the midpoint compared to full year 2025

    COLUMBUS, Ohio, Feb. 11, 2026 /PRNewswire/ — Vertiv Holdings Co (NYSE: VRT), a global leader in critical digital infrastructure, today reported financial results for its fourth quarter and full year ended December 31, 2025. Vertiv reported fourth quarter net sales of $2,880 million, an increase of $534 million, or 23%, compared to fourth quarter 2024, driven by organic sales growth of 19%. Orders momentum accelerated significantly with fourth quarter organic orders up approximately 252% compared to last year’s fourth quarter and up 117% sequentially from third quarter 2025. While the Americas region and hyperscale/colocation data centers were the primary drivers of order strength, order growth was broad-based across regions, technologies and customers. The company’s trailing twelve-month organic orders grew approximately 81% compared to the prior year period, reflecting robust market demand, particularly in AI infrastructure. Fourth quarter 2025 book-to-bill ratio was ~2.9x and backlog increased to $15.0 billion, up 109% compared to the same period last year.

    Fourth quarter operating profit of $580 million increased $123 million and adjusted operating profit of $668 million increased $164 million, up 27% and 33%, respectively, from fourth quarter 2024. Adjusted operating margin was 23.2%, up 170 basis points compared to fourth quarter 2024, driven by operational leverage on higher volume, productivity and favorable price-cost, partially offset by tariff impact.

    “Our fourth quarter performance demonstrates Vertiv’s leadership position in an increasingly complex and demanding data center market,” said Giordano Albertazzi, Vertiv’s Chief Executive Officer. “Significant growth in orders, sales, margins and cash reflects our ability to scale while maintaining a sharp focus on operational execution. What differentiates Vertiv is our ability to anticipate and shape the industry direction. Deep collaborations with semiconductor industry leaders, combined with our decades-long industry expertise and technology-rich portfolio, enable us to optimize customer outcomes by anticipating needs before they become apparent. We architect systems that deliver superior outcomes today and position our customers well to meet tomorrow’s challenges. As we look to 2026, we expect this momentum to continue. Our record backlog provides clear visibility into what we expect to be another year of significant growth.”

    “Today’s results reflect years of strategic focus on technology leadership and value creation,” said Dave Cote, Vertiv’s Executive Chairman. “Our commitment to developing technology that transforms the industry has positioned us as the partner customers turn to for solving their most complex challenges. This technology leadership isn’t just about winning today, it’s about driving sustainable, long-term growth by continuously redefining what’s possible for our customers and the industry.”

    Adjusted Free Cash Flow and Liquidity

    Net cash generated by operating activities in the fourth quarter was $1,005 million and adjusted free cash flow was $910 million, an increase of $580 million and $548 million, respectively, from fourth quarter 2024. Fourth quarter adjusted free cash flow performance was driven by higher adjusted operating profit, working capital efficiency, including project-related advanced payments and lower cash interest, partially offset by higher cash taxes and increased capital expenditures to support growth.

    The company’s strong cash generation enabled Vertiv to deploy approximately $1 billion for strategic growth acquisitions during the quarter while maintaining low leverage and a strong balance sheet. Liquidity remained strong at $2.6 billion and net leverage was approximately 0.5x at the end of fourth quarter, reflecting continued strong operational performance and cash generation. Vertiv continues its commitment to obtaining and maintaining investment grade credit ratings.

    Updated Full Year and First Quarter 2026 Guidance

    The data center market continues to show robust momentum, with strong pipeline growth despite significant pipeline conversion to orders in the fourth quarter. To capitalize on these opportunities, Vertiv is strategically increasing ER&D investments and expanding production capacity.


    First Quarter 2026 Guidance

    Net sales

    $2,500M – $2,700M

    Organic net sales growth(2)

    18% – 26%

    Adjusted operating profit(1)

    $475M – $515M

    Adjusted operating margin(2)

    18.5% – 19.5%

    Adjusted diluted EPS(1)

    $0.95 – $1.01

    Adjusted diluted EPS growth(2)

    48% – 58%






    Full Year 2026 Guidance

    Net sales

    $13,250M – $13,750M

    Organic net sales growth(2)

    27% – 29%

    Adjusted operating profit(1)

    $2,980M – $3,100M

    Adjusted operating margin(2)

    22.0% – 23.0%

    Adjusted diluted EPS(1)

    $5.97 – $6.07

    Adjusted diluted EPS growth(2)

    42% – 45%

    Adjusted free cash flow(2)

    $2,100M – $2,300M

    (1)

    This release contains certain non-GAAP metrics. For reconciliations to the relevant GAAP measures and an explanation of the non-GAAP measures and reasons for their use, please refer to sections of this release entitled “Non-GAAP Financial Measures” and “Reconciliation of GAAP and non-GAAP Financial Measures.”

    (2)

    This is a forward-looking non-GAAP financial measure that cannot be reconciled without unreasonable efforts for those reasons set forth under “Non-GAAP Financial Measures” of this release.

    Fourth Quarter 2025 Earnings Conference Call

    Vertiv’s management team will discuss the Company’s results during a conference call on Wednesday, February 11, starting at 11 a.m. Eastern Time. The call will contain forward-looking statements and other material information regarding Vertiv’s financial and operating results. A webcast of the live conference call will be available for interested parties to listen to by going to the Investor Relations section of the Company’s website at investors.vertiv.com. A slide presentation will be available before the call and will be posted to the website, also at investors.vertiv.com. A replay of the conference call will also be available for 30 days following the webcast.

    About Vertiv Holdings Co

    Vertiv (NYSE: VRT) brings together hardware, software, analytics and ongoing services to enable its customers’ vital applications to run continuously, perform optimally and grow with their business needs. Vertiv solves the most important challenges facing today’s data centers, communication networks and commercial and industrial facilities with a portfolio of power, cooling and IT infrastructure solutions and services that extends from the cloud to the edge of the network. Headquartered in Westerville, Ohio, USA, Vertiv does business in more than 130 countries. For more information, and for the latest news and content from Vertiv, visit vertiv.com.

    Category: Financial News

    Non-GAAP Financial Measures

    Financial information included in this release has been prepared in accordance with Generally Accepted Accounting Principles (“GAAP”). Vertiv has included certain non-GAAP financial measures in this news release, as indicated above, that may not be directly comparable to other similarly titled measures used by other companies and therefore may not be comparable among companies. These non-GAAP financial measures include organic net sales growth (including on a segment basis), adjusted operating profit, adjusted operating margin, adjusted diluted EPS and adjusted free cash flow, which management believes provides investors with useful supplemental information to evaluate the Company’s ongoing operations and to compare with past and future periods. Management also uses certain non-GAAP measures internally for forecasting, budgeting and measuring its operating performance. These measures should be viewed as supplementing, and not as an alternative or substitute for, the Company’s financial results prepared in accordance with GAAP. Pursuant to the requirements of Regulation G, Vertiv has provided reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures.

    Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to first quarter and full-year 2026 guidance, including organic net sales growth, adjusted free cash flow and adjusted operating margin, is not available without unreasonable effort due to high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations. For those reasons, we are unable to compute the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.

    See “Reconciliation of GAAP and Non-GAAP Financial Measures” in this release for Vertiv’s reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures.

    Cautionary Note Concerning Forward-Looking Statements

    This news release, and other statements that Vertiv may make in connection therewith, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to Vertiv’s future financial or business performance, strategies or expectations, and as such are not historical facts. This includes, without limitation, statements regarding Vertiv’s financial position, capital structure, indebtedness, business strategy and plans and objectives of Vertiv management for future operations, as well as statements regarding growth, anticipated demand for our products and services and our business prospects during 2026, as well as expected impacts from our pricing actions, and our guidance for first quarter and full year 2026 and statements regarding tariffs, global trade conflict and any actions we may take in response thereto. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Vertiv cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this news release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

    The forward-looking statements contained in this release are based on current expectations and beliefs concerning future developments and their potential effects on Vertiv. There can be no assurance that future developments affecting Vertiv will be those that Vertiv has anticipated. Vertiv undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond Vertiv’s control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Vertiv has previously disclosed risk factors in its Securities and Exchange Commission (“SEC”) reports, including those set forth in the Vertiv 2024 Annual Report on Form 10-K filed with the SEC on February 18, 2025. These risk factors and those identified elsewhere in this release, among others, could cause actual results to differ materially from historical performance and include, but are not limited to: risks relating to the continued growth of our customers’ markets; long sales cycles for certain Vertiv products and solutions as well as unpredictable placing or cancelling of customer orders; failure to realize sales expected from our backlog of orders and contracts; disruption of or consolidation in our customer’s markets or categorical shifts in customer technology spending; less leverage with large customer contract terms; failure to mitigate risks associated with long-term fixed price contracts; competition in the industry in which we operate; failure to obtain performance and other guarantees from financial institutions; risks associated with governmental contracts; failure to properly manage production cost changes and supply; failure to anticipate market change and competition in the infrastructure technologies; risks associated with information technology disruption or cyber-security incidents; risks associated with the implementation and enhancement of information systems; failure to realize the expected benefit from any rationalization, restructuring and improvement efforts; disruption of, or changes in, Vertiv’s independent sales representatives, distributors and original equipment manufacturers; increase of variability in our effective tax rate costs or liabilities associated with product liability due to global operations subjecting us to income and other taxes in the U.S. and numerous foreign entities; costs or liabilities associated with product liability and damage to our reputation and brands; the global scope of Vertiv’s operations, especially in emerging markets; failure to benefit from future significant corporate transactions; risks associated with Vertiv’s sales and operations and expanding global production facilities; risks associated with future legislation and regulation of Vertiv’s customers’ markets; our ability to comply with various laws and regulations including but not limited to, laws and regulations relating to data protection and data privacy; failure to properly address legal compliance issues, particularly those related to imports/exports, anti-corruption laws, and foreign operations; risks associated with foreign trade policy, including tariffs and global trade conflict risks associated with litigation or claims against the Company, including the risk of adverse outcomes to any legal claims and proceedings; our ability to protect or enforce our proprietary rights on which our business depends; third party intellectual property infringement claims; liabilities associated with environmental, health and safety matters; failure to achieve environmental, social and governance goals; failure to realize the value of goodwill and intangible assets; exposure to fluctuations in foreign currency exchange rates; failure to remediate material weaknesses in our internal controls over financial reporting; our level of indebtedness and our ability to comply with the covenants and restrictions contained in our credit agreements; our ability to access funding through capital markets; resales of Vertiv securities may cause volatility in the market price of our securities; our organizational documents contain provisions that may discourage unsolicited takeover proposals; our certificate of incorporation includes a forum selection clause, which could discourage or limit stockholders’ ability to make a claim against it; the ability of our subsidiaries to pay dividends; factors relating to the business, operations and financial performance of Vertiv and its subsidiaries, including: global economic weakness and uncertainty; our ability to attract, train and retain key members of our leadership team and other qualified personnel; the adequacy of our insurance coverage; fluctuations in interest rates materially affecting our financial results and increasing the risk our counterparties default in our interest rate hedges; our incurrence of significant costs and devotion of substantial management time as a result of operating as a public company; and other risks and uncertainties indicated in Vertiv’s SEC reports or documents filed or to be filed with the SEC by Vertiv. Forward-looking statements included in this news release speak only as of the date of this news release or any earlier date specified for such statements. All subsequent written or oral forward-looking statements attributable to Vertiv or persons acting on Vertiv’s behalf may be qualified in their entirety by this Cautionary Note Concerning Forward-Looking Statements.

    For investor inquiries, please contact:
    Lynne Maxeiner
    Vice President, Global Treasury & Investor Relations
    Vertiv
    E: [email protected]

    For media inquiries, please contact:
    Ruder Finn for Vertiv
    E: [email protected]

     

    Vertiv Holdings Co

    CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) (Unaudited)

    (Dollars in millions except for per share data)

     



    Three months ended
    December 31, 2025


    Three months ended
    December 31, 2024


    Year ended
    December 31, 2025


    Year ended
    December 31, 2024

    Net sales








    Net sales – products

    $                 2,360.5


    $                 1,914.3


    $                 8,390.6


    $                 6,393.5

    Net sales – services

    519.5


    432.1


    1,839.3


    1,618.3

    Net sales

    2,880.0


    2,346.4


    10,229.9


    8,011.8

    Costs and expenses








    Cost of sales – products

    1,466.4


    1,223.8


    5,447.2


    4,099.4

    Cost of sales – services

    292.2


    252.4


    1,067.5


    978.2

    Cost of sales

    1,758.6


    1,476.2


    6,514.7


    5,077.6

    Operating expenses








    Selling, general and administrative expenses                                           

    461.6


    361.6


    1,617.8


    1,374.0

    Amortization of intangibles

    59.3


    47.1


    200.4


    184.2

    Restructuring costs

    20.8


    1.2


    54.5


    5.3

    Foreign currency (gain) loss, net

    6.2


    0.6


    12.0


    9.3

    Other operating expense (income)

    (6.4)


    2.5


    0.8


    (6.0)

    Operating profit (loss)

    579.9


    457.2


    1,829.7


    1,367.4

    Interest expense, net

    16.7


    30.7


    86.1


    150.4

    Loss on extinguishment of debt


    1.3


    1.7


    2.4

    Change in fair value of warrant liabilities


    180.0



    449.2

    Income (loss) before income taxes

    563.2


    245.2


    1,741.9


    765.4

    Income tax expense (benefit)

    117.6


    98.2


    409.1


    269.6

    Net income (loss)

    $                    445.6


    $                    147.0


    $                 1,332.8


    $                    495.8









    Earnings (loss) per share:








    Basic

    $                      1.16


    $                      0.39


    $                      3.49


    $                      1.32

    Diluted

    $                      1.14


    $                      0.38


    $                      3.41


    $                      1.28

    Weighted-average shares outstanding








    Basic

    382,473,479


    376,614,304


    381,712,181


    376,418,933

    Diluted

    391,671,334


    386,473,586


    390,652,824


    386,325,058

    Vertiv Holdings Co

    CONSOLIDATED BALANCE SHEETS (Unaudited)

    (Dollars in millions)

     



    December 31, 2025


    December 31, 2024

    ASSETS




    Current assets:




    Cash and cash equivalents

    $                    1,728.4


    $                    1,227.6

    Short-term investments

    99.5


    Accounts receivable, less allowances of $25.6 and 22.4, respectively

    3,109.0


    2,362.7

    Inventories

    1,456.5


    1,244.4

    Other current assets

    426.1


    267.1

     Total current assets

    6,819.5


    5,101.8

    Property, plant and equipment, net

    921.8


    625.1

    Other assets:




    Goodwill

    2,033.7


    1,321.1

    Other intangible assets, net

    1,894.8


    1,487.1

    Deferred income taxes

    179.6


    303.3

    Right-of-use assets, net

    303.0


    202.1

    Other

    60.0


    92.0

     Total other assets

    4,471.1


    3,405.6

    Total assets

    $                  12,212.4


    $                    9,132.5

    LIABILITIES AND EQUITY




    Current liabilities:




    Current portion of long-term debt

    $                        20.9


    $                         21.0

    Accounts payable

    1,756.4


    1,316.4

    Deferred revenue

    1,814.7


    1,063.3

    Accrued expenses and other liabilities

    771.6


    612.6

    Income taxes

    43.4


    83.7

     Total current liabilities

    4,407.0


    3,097.0

    Long-term debt, net

    2,892.1


    2,907.2

    Deferred income taxes

    232.8


    240.3

    Long-term lease liabilities

    245.2


    171.4

    Other long-term liabilities

    494.0


    282.3

    Total liabilities

    8,271.1


    6,698.2

    Equity




    Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding


    Common stock, $0.0001 par value, 700,000,000 shares authorized, 382,553,680 and 380,703,974 shares issued and   
    outstanding at December 31, 2025 and December 31, 2024, respectively


    Additional paid-in capital

    2,895.2


    2,821.4

    Retained earnings

    1,027.9


    (238.3)

    Accumulated other comprehensive (loss) income

    18.2


    (148.8)

    Total equity

    3,941.3


    2,434.3

    Total liabilities and equity

    $                  12,212.4


    $                    9,132.5

    Vertiv Holdings Co

    CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)

    (Dollars in millions)

     



    ‌              

    Three months ended
    December 31, 2025


    Three months ended
    December 31, 2024


    Year ended
    December 31, 2025


    Year ended
    December 31, 2024

    Cash flows from operating activities:









    Net income (loss)


    $                      445.6


    $                      147.0


    $                   1,332.8


    $                      495.8

    Adjustments to reconcile net income (loss) to net cash
    provided by (used for) operating activities:









     Depreciation


    26.2


    20.9


    97.1


    81.6

     Amortization


    62.1


    50.1


    211.5


    195.4

     Deferred income taxes


    (69.6)


    (1.4)


    22.6


    (54.5)

     Amortization of debt discount and issuance costs


    0.6


    1.5


    5.9


    7.0

     Change in fair value of warrant liabilities



    180.0



    449.2

     Stock-based compensation


    7.2


    8.8


    45.9


    34.6

     Changes in operating working capital


    506.0


    44.9


    339.3


    114.1

     Other


    26.8


    (26.6)


    58.7


    (3.9)

     Net cash provided by (used for) operating
     activities


    1,004.9


    425.2


    2,113.8


    1,319.3

    Cash flows from investing activities:









    Capital expenditures


    (93.3)


    (60.7)


    (220.0)


    (167.0)

    Investments in capitalized software


    (1.7)


    (2.7)


    (6.4)


    (17.1)

    Purchase of short-term investments




    (539.6)


    Proceeds from maturities of short-term investments


    450.0



    450.0


    Acquisition of business, net of cash acquired


    (989.1)


    (17.6)


    (1,184.8)


    (17.6)

    Net cash provided by (used for) investing activities


    (634.1)


    (81.0)


    (1,500.8)


    (201.7)

    Cash flows from financing activities:









    Borrowings from ABL revolving credit facility and short-
    term borrowings





    270.0

    Repayments of ABL revolving credit facility and short-
    term borrowings





    (270.0)

    Repayment of long-term debt


    (5.2)


    (5.2)


    (20.9)


    (21.1)

    Dividend payment


    (24.0)


    (14.1)


    (66.6)


    (42.2)

    Repurchase of common stock





    (599.9)

    Exercise of employee stock options


    4.4


    8.0


    26.4


    33.0

    Employee taxes paid from shares withheld


    (3.2)


    (0.4)


    (11.2)


    (21.9)

     Net cash provided by (used for) financing activities


    (28.0)


    (11.7)


    (72.3)


    (652.1)

    Effect of exchange rate changes on cash and cash
    equivalents


    2.8


    (17.7)


    16.9


    (21.9)

    Increase (decrease) in cash, cash equivalents and
    restricted cash


    345.6


    314.8


    557.6


    443.6

    Beginning cash, cash equivalents and restricted cash


    1,444.2


    917.4


    1,232.2


    788.6

    Ending cash, cash equivalents and restricted cash


    $                   1,789.8


    $                   1,232.2


    $                   1,789.8


    $                   1,232.2

    Changes in operating working capital









    Accounts receivable


    $                    (207.7)


    $                      (89.9)


    $                    (547.5)


    $                    (280.3)

    Inventories


    (21.6)


    (4.5)


    (164.7)


    (369.3)

    Other current assets


    (32.2)


    (16.6)


    (72.9)


    (63.7)

    Accounts payable


    19.1


    84.2


    381.2


    343.1

    Deferred revenue


    668.1


    62.8


    717.5


    434.5

    Accrued expenses and other liabilities


    73.9


    (10.2)


    93.1


    7.0

    Income taxes


    6.4


    19.1


    (67.4)


    42.8

     Total changes in operating working capital


    $                      506.0


    $                        44.9


    $                      339.3


    $                      114.1

    Reconciliation of GAAP and non-GAAP Financial Measures

    To supplement this news release, we have included certain non-GAAP financial measures in the format of performance metrics. Management believes these non-GAAP financial measures provide investors with additional meaningful financial information that should be considered when assessing our underlying business performance and trends. Further, management believes these non-GAAP financial measures also enhance investors’ ability to compare period-to-period financial results. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the company’s reported results prepared in accordance with GAAP. Our non-GAAP financial measures do not represent a comprehensive basis of accounting. Therefore, our non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies. Reconciliations of each of these non-GAAP financial measures to GAAP information are also included. Management uses these non-GAAP financial measures in making financial, operating, compensation and planning decisions and in evaluating the company’s performance. Disclosing these non-GAAP financial measures allows investors and management to view our operating results excluding the impact of items that are not reflective of the underlying operating performance.

    Vertiv’s non-GAAP financial measures include:

    • Adjusted operating profit (loss), which represents operating profit (loss), adjusted to exclude amortization of intangibles, restructuring costs associated with the global restructuring programs, contingent consideration, and merger and acquisition costs;
    • Adjusted operating margin, which represents adjusted operating profit (loss) divided by net sales;
    • Organic net sales growth, which represents the change in net sales adjusted to exclude the impacts of foreign currency exchange rate and acquisitions;
    • Adjusted free cash flow, which represents net cash provided by (used for) operating activities adjusted to exclude capital expenditures and investments in capitalized software; and
    • Adjusted diluted EPS, which represents diluted earnings per share adjusted to exclude amortization of intangibles, restructuring costs associated with global restructuring programs, contingent consideration, merger and acquisition costs, net non-recurring tax adjustments, term loan due 2032 amendment expense and change in warranty liability.

    Regional Segment Results


    Three months ended December 31,


    Year ended December 31,


    2025


    2024


    Δ


    Δ%


    Organic Δ
    %(2)


    2025


    2024


    Δ


    Δ%


    Organic Δ
    %(2)

    Net Sales(1):




















    Americas

    $  1,886.3


    $  1,255.9


    $     630.4


    50.2 %


    46.2 %


    $  6,386.3


    $  4,500.6


    $  1,885.7


    41.9 %


    40.8 %

    APAC

    492.0


    544.0


    (52.0)


    (9.6) %


    (9.3) %


    2,019.2


    1,717.8


    301.4


    17.5 %


    18.2 %

    EMEA

    501.7


    546.5


    (44.8)


    (8.2) %


    (14.1) %


    1,824.4


    1,793.4


    31.0


    1.7 %


    (2.1) %


    $  2,880.0


    $  2,346.4


    $     533.6


    22.7 %


    19.3 %


    $ 10,229.9


    $  8,011.8


    $  2,218.1


    27.7 %


    26.3 %





















    Adjusted operating profit (loss)(3):











    Americas

    $     568.2


    $     321.5


    $     246.7


    76.7 %




    $  1,714.3


    $  1,097.8


    $     616.5


    56.2 %



    APAC

    48.7


    68.4


    (19.7)


    (28.8) %




    222.1


    175.2


    46.9


    26.8 %



    EMEA

    111.0


    145.2


    (34.2)


    (23.6) %




    377.4


    439.4


    (62.0)


    (14.1) %



    Corporate(4)

    (59.8)


    (30.8)


    (29.0)


    94.2 %




    (224.1)


    (160.8)


    (63.3)


    39.4 %




    $     668.1


    $     504.3


    $     163.8


    32.5 %




    $  2,089.7


    $  1,551.6


    $     538.1


    34.7 %























    Adjusted operating margins(5):











    Americas

    30.1 %


    25.6 %


    4.5 %






    26.8 %


    24.4 %


    2.4 %





    APAC

    9.9 %


    12.6 %


    (2.7) %






    11.0 %


    10.2 %


    0.8 %





    EMEA

    22.1 %


    26.6 %


    (4.5) %






    20.7 %


    24.5 %


    (3.8) %





    Vertiv

    23.2 %


    21.5 %


    1.7 %






    20.4 %


    19.4 %


    1.0 %





    (1)

    Segment net sales are presented excluding intercompany sales.

    (2)

    Organic basis is adjusted to exclude foreign currency exchange rate impact and the change in acquisition sales.

    (3)

    Adjusted operating profit (loss) is only adjusted at the Corporate segment. There are no adjustments at the reportable segment level between operating profit (loss) and adjusted operating profit (loss).

    (4)

    Corporate costs consist of headquarters management costs, asset impairments, and costs that support centralized global functions including Finance, Treasury, Risk Management, Strategy & Marketing, Legal, and Human Resources.

    (5)

    Adjusted operating margins calculated as adjusted operating profit (loss) divided by net sales.

    Sales by Product and Service Offering


    Three months ended December 31,


    2025


    2024


    Δ


    Δ %

    Americas:








    Products

    $            1,564.4


    $          1,013.9


    $            550.5


    54.3 %

    Services & spares

    321.9


    242.0


    79.9


    33.0 %


    $            1,886.3


    $          1,255.9


    $            630.4


    50.2 %

    Asia Pacific:








    Products

    $              360.4


    $            417.5


    $             (57.1)


    (13.7) %

    Services & spares

    131.6


    126.5


    5.1


    4.0 %


    $              492.0


    $            544.0


    $             (52.0)


    (9.6) %

    Europe, Middle East & Africa:








    Products

    $              384.6


    $            443.5


    $             (58.9)


    (13.3) %

    Services & spares

    117.1


    103.0


    14.1


    13.7 %


    $              501.7


    $            546.5


    $             (44.8)


    (8.2) %

    Total:








    Products

    $            2,309.4


    $          1,874.9


    $            434.5


    23.2 %

    Services & spares

    570.6


    471.5


    99.1


    21.0 %


    $            2,880.0


    $          2,346.4


    $            533.6


    22.7 %




    Year ended December 31,


    2025


    2024


    Δ


    Δ %

    Americas:








    Products

    $           5,270.1


    $           3,579.1


    $           1,691.0


    47.2 %

    Services & spares

    1,116.2


    921.5


    194.7


    21.1 %


    $           6,386.3


    $           4,500.6


    $           1,885.7


    41.9 %

    Asia Pacific:








    Products

    $           1,510.9


    $           1,248.5


    $             262.4


    21.0 %

    Services & spares

    508.3


    469.3


    39.0


    8.3 %


    $           2,019.2


    $           1,717.8


    $             301.4


    17.5 %

    Europe, Middle East & Africa:








    Products

    $           1,426.0


    $           1,417.6


    $                 8.4


    0.6 %

    Services & spares

    398.4


    375.8


    22.6


    6.0 %


    $           1,824.4


    $           1,793.4


    $               31.0


    1.7 %

    Total:








    Products

    $           8,207.0


    $           6,245.2


    $           1,961.8


    31.4 %

    Services & spares

    2,022.9


    1,766.6


    256.3


    14.5 %


    $         10,229.9


    $           8,011.8


    $           2,218.1


    27.7 %

    Organic growth by Product and Service Offering


    Three months ended December 31, 2025


    Net Sales Δ


    FX Δ


    Acquisition Δ(1)


    Organic growth


    Organic Δ %(2)

    Americas:










    Products

    $                550.5


    $                  (1.7)


    $                (29.3)


    $                519.5


    51.2 %

    Services & spares

    79.9


    (2.3)


    (16.6)


    61.0


    25.2 %


    $                630.4


    $                  (4.0)


    $                (45.9)


    $                580.5


    46.2 %

    Asia Pacific:










    Products

    $                (57.1)


    $                    0.8


    $                     —


    $                (56.3)


    (13.5) %

    Services & spares

    5.1


    0.6



    5.7


    4.5 %


    $                (52.0)


    $                    1.4


    $                     —


    $                (50.6)


    (9.3) %

    Europe, Middle East & Africa:










    Products

    $                (58.9)


    $                (20.8)


    $                  (0.8)


    $                (80.5)


    (18.2) %

    Services & spares

    14.1


    (9.9)


    (0.8)


    3.4


    3.3 %


    $                (44.8)


    $                (30.7)


    $                  (1.6)


    $                (77.1)


    (14.1) %

    Total:










    Products

    $                434.5


    $                (21.7)


    $                (30.1)


    $                382.7


    20.4 %

    Services & spares

    99.1


    (11.6)


    (17.4)


    70.1


    14.9 %


    $                533.6


    $                (33.3)


    $                (47.5)


    $                452.8


    19.3 %

    (1)

    The change in acquisition sales includes sales for the three months ended December 31, 2025, for acquisitions completed in the year ended December 31, 2025.

    (2)

    Organic growth percentage change is calculated as organic growth divided by net sales for the three months ended December 31, 2024.


    Year ended December 31, 2025


    Net Sales Δ


    FX Δ


    Acquisition Δ(1)


    Organic growth


    Organic Δ %(2)

    Americas:










    Products

    $             1,691.0


    $                    5.9


    $                (40.5)


    $             1,656.4


    46.3 %

    Services & spares

    194.7


    0.4


    (16.6)


    178.5


    19.4 %


    $             1,885.7


    $                    6.3


    $                (57.1)


    $             1,834.9


    40.8 %

    Asia Pacific:










    Products

    $                262.4


    $                    7.4


    $                     —


    $                269.8


    21.6 %

    Services & spares

    39.0


    4.1



    43.1


    9.2 %


    $                301.4


    $                  11.5


    $                     —


    $                312.9


    18.2 %

    Europe, Middle East & Africa:










    Products

    $                    8.4


    $                (50.8)


    $                  (0.9)


    $                (43.3)


    (3.1) %

    Services & spares

    22.6


    (16.6)


    (0.8)


    5.2


    1.4 %


    $                  31.0


    $                (67.4)


    $                  (1.7)


    $                (38.1)


    (2.1) %

    Total:










    Products

    $             1,961.8


    $                (37.5)


    $                (41.4)


    $             1,882.9


    30.1 %

    Services & spares

    256.3


    (12.1)


    (17.4)


    226.8


    12.8 %


    $             2,218.1


    $                (49.6)


    $                (58.8)


    $             2,109.7


    26.3 %

    (1)

    The change in acquisition sales includes sales for the year ended December 31, 2025, for acquisitions completed in the year ended December 31, 2025.

    (2)

    Organic growth percentage change is calculated as organic growth divided by net sales for the year ended December 31, 2024.

    Segment information

    Operating profit (loss)

    Three months ended
    December 31, 2025


    Three months ended
    December 31, 2024


    Year ended 
    December 31, 2025


    Year ended
    December 31, 2024

    Americas

    $                      568.2


    $                      321.5


    $                    1,714.3


    $                    1,097.8

    Asia Pacific

    48.7


    68.4


    222.1


    175.2

    Europe, Middle East & Africa                                          

    111.0


    145.2


    377.4


    439.4

    Total reportable segments

    727.9


    535.1


    2,313.8


    1,712.4

    Foreign currency gain (loss)

    (6.2)


    (0.6)


    (12.0)


    (9.3)

    Corporate

    (82.5)


    (30.2)


    (271.7)


    (151.5)

    Total corporate and other

    (88.7)


    (30.8)


    (283.7)


    (160.8)

    Amortization of intangibles

    (59.3)


    (47.1)


    (200.4)


    (184.2)

    Operating profit (loss)

    $                      579.9


    $                      457.2


    $                    1,829.7


    $                    1,367.4

    Reconciliation of net cash provided by (used for) operating activities to adjusted free cash flow


    Three months ended
    December 31, 2025


    Three months ended
    December 31, 2024


    Year ended
    December 31, 2025


    Year ended
    December 31, 2024

    Net cash provided by (used for) operating activities     

    $                    1,004.9


    $                      425.2


    $                    2,113.8


    $                    1,319.3

    Capital expenditures

    (93.3)


    (60.7)


    (220.0)


    (167.0)

    Investments in capitalized software

    (1.7)


    (2.7)


    (6.4)


    (17.1)

    Adjusted free cash flow

    $                      909.9


    $                      361.8


    $                    1,887.4


    $                    1,135.2

    Reconciliation from operating profit (loss) to adjusted operating profit (loss)


    Three months ended
    December 31, 2025


    Three months ended
    December 31, 2024


    Year ended 
    December 31, 2025


    Year ended
    December 31, 2024

    Operating profit (loss)

    $                      579.9


    $                      457.2


    $                    1,829.7


    $                    1,367.4

    Amortization of intangibles

    59.3


    47.1


    200.4


    184.2

    Restructuring costs – global programs                                 

    18.8



    49.5


    Contingent consideration

    4.9



    4.9


    Mergers and acquisition costs

    5.2



    5.2


    Adjusted operating profit (loss)

    $                      668.1


    $                      504.3


    $                    2,089.7


    $                    1,551.6

    Reconciliation from operating margin to adjusted operating margin


    Three months ended
    December 31, 2025


    Three months ended
    December 31, 2024


    Δ


    Year ended
    December 31, 2025


    Year ended
    December 31, 2024


    Δ

    Vertiv net sales

    $              2,880.0


    $              2,346.4


    $   533.6


    $          10,229.9


    $            8,011.8


    $ 2,218.1

    Vertiv operating profit (loss)

    579.9


    457.2


    122.7


    1,829.7


    1,367.4


    462.3

    Vertiv operating margin

    20.1 %


    19.5 %


    0.6 %


    17.9 %


    17.1 %


    0.8 %













    Amortization of intangibles

    $                   59.3


    $                   47.1


    $     12.2


    $               200.4


    $               184.2


    $     16.2

    Restructuring costs – global programs

    18.8



    18.8


    49.5



    49.5

    Contingent consideration

    4.9



    4.9


    4.9



    4.9

    Mergers and acquisition costs

    5.2



    5.2


    5.2



    5.2

    Vertiv adjusted operating profit (loss)

    668.1


    504.3


    163.8


    2,089.7


    1,551.6


    538.1

    Vertiv adjusted operating margin

    23.2 %


    21.5 %


    1.7 %


    20.4 %


    19.4 %


    1.0 %

    Reconciliation of Diluted EPS to Non-GAAP Adjusted EPS

    Three months ended December 31, 2025










    Operating profit (loss)


    Interest expense, net


    Income tax expense
    (benefit)


    Net income (loss)


    Diluted EPS(1)

    GAAP

    $                      579.9


    $                        16.7


    $                      117.6


    $                      445.6


    $                        1.14

    Amortization of intangibles

    59.3




    59.3


    0.15

    Restructuring costs – global programs                     

    18.8




    18.8


    0.05

    Contingent consideration

    4.9




    4.9


    0.01

    Mergers and acquisition costs

    5.2




    5.2


    0.01

    Non-GAAP Adjusted

    $                      668.1


    $                        16.7


    $                      117.6


    $                      533.8


    $                        1.36

    Diluted shares (in millions)









    391.7

    (1)

    Diluted EPS and adjusted diluted EPS is based on 391.7 million shares (includes 382.5 million basic shares and 9.2 million potential dilutive equity awards).

    Three months ended December 31, 2024














    Operating
    profit (loss)


    Interest
    expense, net


    Loss on
    extinguishment of
    debt


    Change in
    warrant liability


    Income tax
    expense (benefit)


    Net income
    (loss)


    Diluted EPS(1)

    GAAP

    $            457.2


    $              30.7


    $                    1.3


    $              180.0


    $              98.2


    $            147.0


    $               0.38

    Amortization of intangibles

    47.1






    47.1


    0.12

    Change in warrant liability




    (180.0)


    (37.5)


    217.5


    0.56

    Nonrecurring tax benefit, net(2)         





    27.1


    (27.1)


    (0.07)

    Non-GAAP Adjusted

    $            504.3


    $              30.7


    $                    1.3


    $                   —


    $              87.8


    $            384.5


    $               0.99

    Diluted shares (in millions)













    386.5

    (1)

    Diluted EPS and adjusted diluted EPS is based on 386.5 million shares (includes 376.6 million basic shares and 9.9 million potential dilutive equity awards). We believe that this presentation is more representative of operating results by removing the impact of warrant liability accounting and the associated impact on diluted share count.

    (2)

    Nonrecurring tax benefit includes $27.1 million of valuation allowance release as a result of the Company’s updated assessment of the realization of deferred tax assets in certain countries.

    Year ended December 31, 2025












    Operating profit
    (loss)


    Interest expense,
    net


    Loss on
    extinguishment of
    debt


    Income tax
    expense (benefit)


    Net income
    (loss)


    Diluted EPS(1)

    GAAP

    $              1,829.7


    $                   86.1


    $                    1.7


    $                 409.1


    $              1,332.8


    $                   3.41

    Amortization of intangibles

    200.4





    200.4


    0.52

    Restructuring costs – global programs

    49.5





    49.5


    0.13

    Contingent consideration

    4.9





    4.9


    0.01

    Mergers and acquisition costs

    5.2





    5.2


    0.01

    Nonrecurring tax benefit, net(2)




    (39.5)


    39.5


    0.10

    Term loan due 2032 amendment expense(3)


    (6.2)


    (1.7)



    7.9


    0.02

    Non-GAAP Adjusted

    $              2,089.7


    $                   79.9


    $                      —


    $                 369.6


    $              1,640.2


    $                   4.20

    Diluted shares (in millions)











    390.7

    (1)

    Diluted EPS and adjusted diluted EPS is based on 390.7 million shares (includes 381.7 million basic shares and 9.0 million potential dilutive equity awards).

    (2)

    Nonrecurring tax benefit includes $39.5 million of valuation allowance release as a result of the Company’s updated assessment of the realization of deferred tax assets in certain countries.

    (3)

    Costs associated with the August 12, 2025 amendment of the Term Loan due 2032.

    Year ended December 31, 2024














    Operating
    profit (loss)


    Interest
     expense, net


    Loss on
    extinguishment of
    debt


    Change in
    warrant liability


    Income tax
    expense
    (benefit)


    Net income
    (loss)


    Diluted EPS(1)

    GAAP

    $              1,367.4


    $                   150.4


    $                               2.4


    $                     449.2


    $                   269.6


    $                  495.8


    $                      1.28

    Amortization of intangibles

    184.2






    184.2


    0.48

    Change in warrant liability




    (449.2)



    449.2


    1.16

    Nonrecurring tax benefit, net(2)





    27.1


    (27.1)


    (0.07)

    Non-GAAP Adjusted

    $              1,551.6


    $                   150.4


    $                               2.4


    $                             —


    $                   296.7


    $              1,102.1


    $                      2.85

    Diluted shares (in millions)













    386.3

    (1)

    Diluted EPS and adjusted diluted EPS is based on 386.3 million shares (includes 376.4 million basic shares and 9.9 million potential dilutive equity awards). We believe that this presentation is more representative of operating results by removing the impact of warrant liability accounting and the associated impact on diluted share count.

    (2)

    Nonrecurring tax benefit includes $27.1 million of valuation allowance release as a result of the Company’s updated assessment of the realization of deferred tax assets in certain countries.

    Vertiv Holdings Co

    2026 Adjusted Guidance

    Reconciliation of GAAP Operating Profit to Non-GAAP Adjusted Financial Performance(1)

     


    First Quarter 2026










    Operating profit (loss)


    Interest expense, net


    Income tax expense
    (benefit)


    Net income (loss)


    Diluted EPS(2)

    GAAP

    $                      424.8


    $                        18.7


    $                        93.4


    $                      312.7


    $                        0.80

    Amortization of intangibles     

    70.4




    70.4


    0.18

    Non-GAAP Adjusted

    $                      495.2


    $                        18.7


    $                        93.4


    $                      383.1


    $                        0.98

    Diluted shares (in millions)









    392.0



















    Full Year 2026










    Operating profit (loss)


    Interest expense, net


    Income tax expense
    (benefit)


    Net income (loss)


    Diluted EPS(2)

    GAAP

    $                    2,765.4


    $                        59.0


    $                      622.5


    $                    2,083.9


    $                        5.32

    Amortization of intangibles

    274.4




    274.4


    0.70

    Non-GAAP Adjusted

    $                    3,039.8


    $                        59.0


    $                      622.5


    $                    2,358.3


    $                        6.02

    Diluted shares (in millions)









    392.0

    (1)

    Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to FY 2026 guidance, including organic net sales growth, adjusted operating margin and adjusted free cash flow, is not available without unreasonable effort due to high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations. For the same reasons, we are unable to compute the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.

    (2)

    Diluted EPS and adjusted diluted EPS based on 392.0 million shares (includes 383.0 million basic shares and a weighted average 9.0 million potential dilutive equity awards).

    SOURCE Vertiv Holdings Co

    Continue Reading

  • VISTA PLACES MAJOR CHALLENGER 3500 ORDER WITH BOMBARDIER, SECURING CAPACITY FOR THE NEXT DECADE

    VISTA PLACES MAJOR CHALLENGER 3500 ORDER WITH BOMBARDIER, SECURING CAPACITY FOR THE NEXT DECADE

    40 firm aircraft with 120 options ordered by Vista and its commonly controlled entities reinforce the Group’s long-term growth strategy and global leadership in private aviation 

    DUBAI, UAE, Feb. 11, 2026 /PRNewswire/ — Vista, the world’s leading private aviation group, announced a major fleet agreement with Bombardier, comprising 40 firm orders for the industry leading Challenger 3500 aircraft and 120 additional purchase options. The agreement secures long-term capacity for Vista’s ever growing Member base as global demand for premium private aviation continues to expand.

    Deliveries will begin immediately in 2026 and be phased over up to the next 10 years, aligning fleet growth with utilization and regional demand for Vista’s unique global network of silver with a red stripe aircraft. The structure provides Vista with significant flexibility while ensuring readiness to serve Members around the world as travel patterns evolve. It also consolidates Vista’s demand for its Super-Midsize offering on one common platform, which grants clients an identical experience anywhere, anytime. From an operational perspective, this level of scale on one common platform will further drive efficiencies. 

    “This agreement is about leadership, preparedness and client experience,” said Thomas Flohr, Founder and Chairman of Vista. “We are continuing to build the fleet our Members will rely on over the next decade, not reacting to short-term cycles, but investing with clarity, scale and discipline.” 

    Vista operates the world’s largest global private aviation platform, serving its clients across 96% of the world’s countries through its VistaJet and XO brands. The order comes off the back another year of consecutive double-digit growth on the Group’s multi-year subscription based Program product. In 2025 the Program Member base grew by 12% and Vista flew 16% more live Program hours year-over-year. Program live hours growth was delivered across all markets, with the Group’s core regions of the U.S. and Europe being the largest contributors — up 11% and 15% respectively. Emerging regions continued their impressive trajectory following targeted sales strategies in these areas — the Middle East, Asia and Africa saw Program live hours correspondingly growing 32%, 22% and 30%.

    The Challenger 3500 plays a central role in Vista’s fleet strategy, offering exceptional range, reliability and cabin innovation. Vista continues to lead and pioneer the client experience on board — in the past by introducing the pocket door for privacy; then the jump seat for the Cabin Host to ensure every Vista flight is operated with full service; and today, the Challenger 3500 is recognized for featuring the most technologically advanced cabin in its class, with productivity-enhancing features such as the industry’s first voice-controlled cabin, a completely redesigned interior and patented Nuage zero gravity seats.

    This agreement follows Vista’s recent completion of its fleet-wide cabin harmonization program and the roll out of next generation highest speed connectivity, positioning the Group for its next phase of growth. 

    “Bombardier jets pioneered the super-midsize aircraft category, and with the Challenger 3500 aircraft we continue to raise the bar for customers when it comes to offering a full package of performance, reliability and cabin comfort,” said Éric Martel, President and CEO, Bombardier.This significant order is a testament to how well this aircraft serves our customers, delivering the perfect balance of cutting-edge technology, exceptional comfort, and proven value. Vista has been a valued Bombardier customer since they began operating. We are proud that our relationship will further deepen through this significant order and are excited for Vista’s teams and clients to benefit from everything the Challenger 3500 aircraft has to offer.” 

    With this agreement, Vista reinforces its position as the industry’s most scaled, resilient and future-oriented private aviation group, investing to deliver unmatched availability, consistency and service worldwide.

    About Vista

    Vista Global Holding Limited (Vista) is the world’s leading global business aviation company providing worldwide business flight services through its network of subsidiaries and a team of over  4,000 experts. A global group headquartered in Dubai, Vista integrates a unique portfolio of companies to offer asset free services to cover all key aspects of business aviation, including guaranteed and on demand global flight coverage, subscription and membership solutions, and trading and management services.

    Innovating the industry for over 20 years through continuous investment in talent, technology, and infrastructure, Vista’s mission is to provide the most advanced flying services at the very best value — anytime, anywhere around the world.

    Vista’s extensive industry expertise enables it to deliver comprehensive end-to-end solutions and technology to meet the needs of business aviation clients around the world. These services are offered through its leading brands, including VistaJet and XO.

    More Vista information and news at www.vistaglobal.com 

    Photo – https://mma.prnewswire.com/media/2901971/Bombardier_Challenger_3500_VistaJet.jpg
    Logo – https://mma.prnewswire.com/media/2755695/5782088/Vista_Logo.jpg

    SOURCE Vista

    Continue Reading

  • Akeso’s IL-4Rα/ST2 Bispecific Antibody Cleared for Seven Phase II Studies in China Spanning Respiratory and Autoimmune Indications

    HONG KONG, Feb. 11, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) is pleased to announce that the National Medical Products Administration has approved the initiation of Phase II clinical trials for AK139,  a first-in-class IL-4Rα/ST2-targeting bispecific antibody, across seven indications. These indications include chronic obstructive pulmonary disease (COPD), severe bronchial asthma, chronic spontaneous urticaria, allergic rhinitis, chronic rhinosinusitis with nasal polyps, moderate-to-severe atopic dermatitis, and prurigo nodularis. With these new Phase II studies, AK139 has the potential to bring its novel mechanism of action to create breakthrough therapies for multiple respiratory and autoimmune indications

    AK139 is a clinical stage bispecific antibody for autoimmune indications that was discovered using Akeso’s proprietary AI-enabled drug discovery platform. It marks a pivotal expansion of the company’s leading expertise in bispecific/multispecific antibody for oncology into other major therapeutic areas.  Chronic inflammatory diseases driven by the IL-4Rα/ST2 pathway, including key respiratory and autoimmune disorders, are characterized by complex pathogenesis and a substantial patient burden worldwide. Significant unmet clinical needs persist in many of these indications due to insufficient responses or limited symptom control from current single-target therapies.

    As the world’s first IL-4Rα/ST2 bispecific antibody to enter the clinic, AK139 simultaneously targets and blocks both the IL-4/IL-13 pathway (by binding to the IL-4Rα subunit shared by both IL-4 and IL-13 receptor complexes) and the IL-33/ST2-mediated inflammation pathway. Early studies show that AK139 possesses strong bispecific binding affinity, as well as favorable in vitro and in vivo pharmacological activity. In key metrics, including inhibition of inflammatory cytokine release and reduction of tissue inflammatory cell infiltration, AK139 demonstrates significantly greater synergistic efficacy compared to single-target antibodies against either IL-4 or ST2. AK139 also has a good safety profile from earlier studies.

    To date, no antibody drug targeting both the IL-4Rαand the IL-33/ST2 pathways has been approved or is in clinical studies. By simultaneously inhibiting these core inflammatory pathways, AK139 has the potential to advance the treatment of related respiratory, autoimmune, and dermatological diseases into a “dual-target era,” offering patients a superior and broad spectrum therapeutic solution. The expansion and advancement of AK139’s global clinical development program will further strengthen Akeso’s momentum in autoimmune diseases. This progress builds upon the foundation established by approved or late-stage novel autoimmune therapies in Akeso’s portfolio, such as ebdarokimab (IL-12/IL-23), gumokimab (IL-17A), and manfidokimab (IL-4R).

    Forward-Looking Statement of Akeso, Inc.
    This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

    Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

    Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

    About Akeso
    Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has established a robust R&D innovation ecosystem centered on its proprietary Tetrabody bispecific antibody platform, ADC (Antibody-Drug Conjugate) technologies, siRNA/mRNA modalities, and cell therapies. Supported by a global-standard GMP manufacturing infrastructure and a highly efficient, integrated commercialization model, the company has evolved into a globally competitive biopharmaceutical focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 26 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

    For more information, please visit https://www.akesobio.com/en/about-us/corporate-profile/ and follow us on Linkedin.

    SOURCE Akeso, Inc.

    Continue Reading

  • Experian announces integration with Snowflake’s AI Data Cloud

    Experian announces integration with Snowflake’s AI Data Cloud

    Aperture Data Studio, running on Snowflake, will help customers build a trusted data foundation where their data lives

    London, 11th February, 2026 – Global data and technology company Experian today announces the launch of its Aperture Data Studio integration with Snowflake, the AI Data Cloud company.

    The integration enables organisations to leverage Aperture Data Studio’s powerful data quality capabilities to profile, transform, and validate data directly within the Snowflake platform.

    By connecting with Snowflake’s AI Data Cloud, Experian has joined Snowflake in mobilising the world’s data to help organisations confidently manage trusted data with a focus on speed, security and simplicity. The combined solution, now available globally, addresses data quality issues without moving data, enabling joint Snowflake and Aperture Data Studio customers to:

    ●      Keep data secure: Data stays within Snowflake’s secure perimeter, reducing risk and enabling compliance.

    ●      Accelerate data management: Create workflows in Aperture Data Studio’s intuitive interface and execute them near-instantly in Snowflake.

    ●      Unify data quality and governance efforts: Empower users to efficiently catalogue, manage and control data while offering accuracy, compliance and confidence at scale.

    Andrew Abraham, Global Managing Director, Data Quality, Experian, said: “Data is the foundation of every transformation, yet many businesses struggle to turn it into real business value.

    “With the rapid emergence of AI technologies, quality, accurate data is fundamental to its success. Our collaboration with Snowflake brings together Experian’s expertise in data quality and governance with the scale, performance and flexibility of Snowflake’s platform.

    “This will allow businesses to not only innovate faster, stay compliant, and reduce risk, but also make trusted data a reality. Today marks the start of our joint efforts to bring Experian’s powerful data quality capabilities to where Snowflake customer data lives.”

    Rinesh Patel, Global Head of Financial Services, Snowflake, said: “With the launch of Experian’s integration with the Snowflake AI Data Cloud, we look forward to driving deeper value for our joint customers.

    “This integration enables customers to build a trusted, compliant data foundation that reduces risk, accelerates AI adoption and supports smarter decision‑making.”

                                                                                                                                   ENDS

    Experian Aperture Data Studio combines data quality and governance for data, models and AI agents into one intuitive, scalable platform. The platform ensures your data is always fit for purpose, compliant and ready to power your big ambitions. By partnering with Snowflake, Aperture Data Studio workflows are now available to clients who manage their data on the Snowflake platform.

    Snowflake AI Data Cloud Product Partners help customers maximise Snowflake’s flexibility, performance, and ease of use to deliver more meaningful insights. AI Data Cloud Services Partners provide industry experience, technical expertise, and strategic best practices to help customers mitigate risk and drive business value with Snowflake throughout their entire data and AI journey. To learn more about becoming an AI Data Cloud partner, click here

    Media contact:

    Robert Goodman, PR Manager, Corporate & Business, UK&I, Experian

    Tel: +44 7989 398 498 / Email: Robert.Goodman@Experian.com

    About Experian

    Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

    We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

    We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

     

     

    Continue Reading

  • Medidata Delivers a Decade of AI Leadership to 500+ Clinical Studies and Growing

    Medidata Delivers a Decade of AI Leadership to 500+ Clinical Studies and Growing

    Powered by Medidata’s AI technologies, complex clinical data is transformed, delivering significantly faster study build and shorter trial timelines

    New York – Feb. 11, 2026 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, continues to accelerate clinical trial success for biopharmaceutical and medtech customers through enhanced AI-powered capabilities. Its AI technology has been scaled across the Medidata Platform, benefiting over 500 clinical studies in the last decade, including more than 120 AI-supported studies starting in 2025.

    Building on its established AI foundation, Medidata continues to seamlessly weave intelligence into more solutions across its unified platform. The latest advancements include significant enhancements to Medidata Designer with the introduction of Medidata AI Study Build. The new capability accelerates study builds by leveraging the study protocol and generative AI to configure Medidata Rave EDC and Medidata eCOA systems, drastically reducing the time required to move from protocol to start-up. This delivers faster study build times, dramatically speeding time-to-market for sponsors and critical decision-making for CROs.

    “Leveraging our large clinical data set from more than 38,000 trials, Medidata’s AI is redefining clinical trials, with its impact now evolving from pervasive embedding to quantifiable outcomes,” said Lisa Moneymaker, chief strategy officer, Medidata. “By prioritizing clinically-fluent, regulatory-grade AI to drive results across the trial lifecycle, we are helping our customers turn complexity into clarity and data into decisive action. Our foundational AI engine delivers platform capabilities that allow development teams to focus on resources for advancing patient care.”

    To deliver truly intelligent automation, Medidata is accelerating the expansion of Dot, its core AI orchestrator that coordinates and connects the actions of domain specific AI Companions across the platform. The visual presence of Dot enables customers to instantly recognize and access the power of AI built into every step of the clinical trial process. This clear visibility accelerates the use of AI to advance new therapies to patients faster.

    “As the life sciences industry increasingly moves toward embedded, enterprise AI solutions, Medidata’s AI Study Build has the potential to transform complex database build processes and accelerate market access, while Dot ensures transparency and builds trust in the use of AI,” said Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy & Technology, at IDC.

    To learn more about Medidata’s AI capabilities, click here.  

    Continue Reading